Physician profile
Robert H Connaughton
NPI 1326061003
$6,445.88
in general payments reported to CMS, 2019-2025
18 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $95.32 · 2021: $122 · 2022: $300 · 2023: $3,863 · 2024: $1,170 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $1,378 · Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $1,377.85 |
| Food and Beverage | $934.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,920.80 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Silk Road Medical, INC. | $812.86 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cardiovascular Systems INC. | $468.14 | 2019 | |
| Medtronic, INC. | $363.71 | 2022-2025 | In.Pact Admiral, Dextile, Venaseal |
| Cook Medical LLC | $291.93 | 2019-2022 | |
| Tela Bio, INC. | $102.12 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Sirtex Medical INC | $76.01 | 2024 | Sir-Spheres Microspheres |
| Nxstage Medical, INC. | $64.28 | 2021 | |
| Bard Peripheral Vascular, INC. | $63.68 | 2019-2025 | Rotarexs 6 F X 135 Cm |
| Lemaitre Vascular, INC. | $58.43 | 2024 | Artegraft Vascular Graft |
| Davol INC. | $49.35 | 2024 | Phasix Mesh |
| Penumbra, INC. | $45.00 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $38.12 | 2025 | Phasix Mesh |
| Abbott Laboratories | $24.11 | 2020 | |
| Acera Surgical, INC. | $22.32 | 2024 | Restrata Wound Matrix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $20.07 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| W. L. Gore & Associates, INC. | $13.77 | 2019 | |
| Reflow Medical INC | $11.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Connaughton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.